Saxenda vs Wegovy

Why Saxenda Failed Where Wegovy Succeeded

by

Saxenda introduced GLP-1 weight-loss therapy to mainstream obesity medicine, but Wegovy dramatically changed expectations with stronger appetite suppression, weekly dosing, and substantially greater weight-loss results. Here’s why semaglutide overtook liraglutide in modern obesity treatment.

Saxenda vs Wegovy: Which Creates More Sustainable Weight-Loss Habits?

by

Saxenda and Wegovy both belong to the GLP-1 drug class, but their differences in dosing, effectiveness, and appetite control may significantly influence long-term weight-loss habits. Here’s how semaglutide and liraglutide compare in real-world obesity management.